ECHO-306/KEYNOTE-715: A phase 3 study of first-line epacadostat plus pembrolizumab with or without platinum-based chemotherapy vs pembrolizumab plus platinum-based chemotherapy plus placebo for metastatic non–small cell lung cancer (mNSCLC)

Journal article

Peer reviewed

Rina Hui, Mihaela Munteanu, Yufan Zhao, Yiwen Luo, Ayman Samkari and Marina Chiara Garassino

Journal of clinical oncology, v 36(15_suppl), pp TPS9104-TPS9104

20 May 2018

Additional Links

Abstract only

7 Record Views

Title: ECHO-306/KEYNOTE-715: A phase 3 study of first-line epacadostat plus pembrolizumab with or without platinum-based chemotherapy vs pembrolizumab plus platinum-based chemotherapy plus placebo for metastatic non–small cell lung cancer (mNSCLC)
Creators: Rina Hui - Westmead Hospital
Mihaela Munteanu - Incyte (United States)
Yufan Zhao - Incyte (United States)
Yiwen Luo - Merck & Co., Inc, Kenilworth, NJ
Ayman Samkari - Merck & Co., Inc., Rahway, NJ, USA (United States)
Marina Chiara Garassino - Fondazione IRCCS Istituto Nazionale dei Tumori
Publication Details: Journal of clinical oncology, v 36(15_suppl), pp TPS9104-TPS9104
Resource Type: Journal article
Language: English
Academic Unit: Pediatrics
Web of Science ID: WOS:000442916008008
Other Identifier: 991021838705304721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Oncology